{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T16:32:14Z","timestamp":1717518734166},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.bbrc.2018.04.149","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T12:36:54Z","timestamp":1525437414000},"page":"64-72","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia"],"prefix":"10.1016","volume":"501","author":[{"given":"Ziye","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.04.149_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.04.149_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2141.2000.02137.x","article-title":"The story of chronic myeloid leukaemia","volume":"110","author":"Geary","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2018.04.149_bib3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.04.149_bib4","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.04.149_bib5","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.04.149_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ijc.23514","article-title":"DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines","volume":"123","author":"Kawamoto","year":"2008","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.bbrc.2018.04.149_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00384-007-0355-2","article-title":"SFRP2 methylation in fecal DNA\u2013a marker for colorectal polyps","volume":"23","author":"Oberwalder","year":"2008","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.bbrc.2018.04.149_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/carcin\/bgy009","article-title":"Chemoprevention of colorectal cancer by black raspberry anthocyanins involved the modulation of gut microbiota and SFRP2 demethylation","volume":"39","author":"Chen","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2018.04.149_bib9","doi-asserted-by":"crossref","first-page":"36354","DOI":"10.18632\/oncotarget.16754","article-title":"Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.04.149_bib10","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3892\/or.2015.4221","article-title":"Promoting roles of the secreted frizzled-related protein 2 as a Wnt agonist in lung cancer cells","volume":"34","author":"Xiao","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2018.04.149_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00277-005-1039-z","article-title":"Chronic myeloid leukemia: a model for oncology","volume":"84","author":"Hehlmann","year":"2005","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bbrc.2018.04.149_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.04.149_bib13","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.04.149_bib14","doi-asserted-by":"crossref","first-page":"e3114","DOI":"10.1038\/cddis.2017.458","article-title":"BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy","volume":"8","author":"Pereira","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2018.04.149_bib15","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/leu.2016.143","article-title":"Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia","volume":"30","author":"Heller","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2018.04.149_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12935-018-0523-1","article-title":"A.O. 0000-0002-9644-7098, MLL2\/KMT2D and MLL3\/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia","volume":"18","author":"DDA","year":"2018","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.bbrc.2018.04.149_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2141.2008.07242.x","article-title":"Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia","volume":"142","author":"Jost","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2018.04.149_bib18","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1182\/blood-2011-05-354712","article-title":"Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia","volume":"118","author":"Cheng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.04.149_bib19","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1158\/1078-0432.CCR-06-1194","article-title":"Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA","volume":"12","author":"Urakami","year":"2006","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2018.04.149_bib20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/1535370213498984","article-title":"DNA methyltransferase inhibitor-mediated apoptosis in the Wnt\/beta-catenin signal pathway in a renal cell carcinoma cell line","volume":"238","author":"Konac","year":"2013","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbrc.2018.04.149_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature17392","article-title":"sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance","volume":"532","author":"Kaur","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.04.149_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.cellbio.14.1.59","article-title":"Mechanisms of Wnt signaling in development","volume":"14","author":"Wodarz","year":"1998","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2018.04.149_bib23","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/leu.2009.86","article-title":"Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia","volume":"23","author":"Valencia","year":"2009","journal-title":"Leukemia"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18309306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18309306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T15:51:45Z","timestamp":1604245905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18309306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0006291X18309306"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.149","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}